30th Oct 2012 16:25
For Immediate Release | 30 October 2012 |
Alliance Pharma plc
TR-1: Notification of Major Interest in Shares
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: | Alliance Pharma plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | x | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
An event changing the breakdown of voting rights | ||||
Other (please specify): | On market transfers between indirect and direct funds | |||
3. Full name of person(s) subject to thenotification obligation: | Artemis Investment Management LLP on behalf of discretionary funds under management | |||
4. Full name of shareholder(s) (if different from 3.): | ||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: | 25 October 2012 | |||
6. Date on which issuer notified: | 26 October 2012 | |||
7. Threshold(s) that is/are crossed orreached: | 5% | |||
8. Notified details: | |||||||||||
A: Voting rights attached to shares | |||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | |||||||
Direct | Direct | Indirect | Direct | Indirect | |||||||
Ordinary SharesGB0031030819 | 11,336,249 | 11,336,249 | 12,136,249 | 12,136,249 | 5.04% | ||||||
| |||||||||||
B: Qualifying Financial Instruments | |||||||||||
Resulting situation after the triggering transaction | |||||||||||
Type of financialinstrument | Expirationdate | Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | |||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financialinstrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to
| % of voting rights
| |
| Nominal | Delta | ||||
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
12,136,249 | 5.04% |
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will ceaseto hold: | ||
12. Date on which proxy holder will cease to holdvoting rights: | ||
13. Additional information: |
| |
14. Contact name: | Richard Smithson | |
15. Contact telephone number: | 020 7399 6063 | |
Related Shares:
Alliance Pharma